I agree with you on POZN $heff. I own a lot of that one too. Don't forget they are working on a third drug that is somewhat of a substitute for aspirin which is suppose to be easier on the stomach. If approved, that could easily be their biggest selling drug. No reason why this company can't have a $1 billion market cap with just Treximet and this new potentially FDA approved drug alone. Imo, they will be bought out, perhaps by Astra Zeneca.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"